Share This Article:

Selective Cytotoxicity and Apoptogenic Activity of Hibiscus Sabdariffa Aqueous Extract Against MCF-7 Human Breast Cancer Cell Line

Abstract Full-Text HTML Download Download as PDF (Size:329KB) PP. 394-400
DOI: 10.4236/jct.2011.23054    6,865 Downloads   15,204 Views   Citations

ABSTRACT

Background: Herbal compounds are attractive anticancer candidates due to their low toxicity. Pervious studies have demonstrated that Hibiscus sabdariffa is promising as an anticancer agent against several cancer types; however, its potential therapeutic role in breast cancer remains to be investigated. Materials and Methods: In the present study, the cytotoxic effects of Hibiscus sabdariffa aqueous extract (HSE) on a human breast adenocarcinoma cell line (MCF-7) and fetal foreskin fibroblast (HFFF) were investigated. Different concentrations of water extract of calyces were added and the percentage of cell survival was determined after 24, 48, and 72 hours using an MTT assay. Apoptosis induction was assessed by DNA fragmentation. Results: At the concentration of 0.5 mg/ml of the extract and following 72 hours of incubation, the number of viable MCF-7 cells was less than 50%. The extract was not cytotoxic against normal HFFF cells in all tested concentrations. Also, HSE induced apoptosis only in MCF-7 cells. Conclusions: These results suggest that HSE inhibits the growth of MCF-7 cells selectively in a concentration- and time-dependent manner. As this herbal substance has been shown to be nontoxic at very high doses in experimental animals, it might be a good anticancer drug candidate for breast cancer treatment.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

S. Khaghani, F. Razi, M. Yajloo, M. Paknejad, A. Shariftabrizi and P. Pasalar, "Selective Cytotoxicity and Apoptogenic Activity of Hibiscus Sabdariffa Aqueous Extract Against MCF-7 Human Breast Cancer Cell Line," Journal of Cancer Therapy, Vol. 2 No. 3, 2011, pp. 394-400. doi: 10.4236/jct.2011.23054.

References

[1] C. Andreetta, A. M. Minisini, M. Miscoria and F. Puglisi, “First-Line Chemotherapy with or without Biologic Agents for Metastatic Breast Cancer,” Oncology Hematology, Vol. 76, No. 2, 2010, pp. 99-111. doi:10.1016/j.critrevonc.2010.01.007
[2] A. Jemal, R. Siegel, J. Xu and E. Ward, “Cancer Statistics, 2010,” A Cancer Journal for Clinicians, Vol. 60, No. 5, 2010, pp. 277-300. doi:10.3322/caac.20073
[3] F. Valeriote and L. Putten, “Proliferation Dependent Cytotoxic Action of Anti Cancer Agents: A Review,” Cancer Research, Vol. 35, No. 10, 1975, pp. 2619-2630.
[4] M. P. Deonarain and A. A. Epenetos,“Targeting Enzymes for Cancer Therapy: Old Enzymes in New Roles,” British Journal of Cancer, Vol. 70, 1994, pp. 786-794. doi:10.1038/bjc.1994.400
[5] D. J. Newman and G. M. Cragg, “Natural Products as Sources of New Drugs over the Last 25 Years,” Journal of National Products, Vol. 70, 2007, pp. 461-477. doi:10.1021/np068054v
[6] H. Roberts, “Safety of Herbal Medicinal Products in Women with Breast Cancer,” Maturitas, Vol. 66, No. 4, 2010, pp. 363-369. doi:10.1016/j.maturitas.2010.02.010
[7] L. Y. Wong, P. C. Leung, J. L. Tang and S. W. Mercer, “Use of Dietary Supplements by Breast Cancer Patients Undergoing Conventional Cancer Treatment,” Patient Prefer Adherence, Vol. 4, 2010, pp. 407-414. doi:10.2147/PPA.S13639
[8] E. Ernst, K. Schmidt and M. Baum, “Complementary/Alternative Therapies for the Treatment of Breast Cancer. A Systematic Review of Randomized Clinical Trials and a Critique of Current Terminology,” The Breast Journal, Vol. 12, No. 6, 2006, pp. 526-530. doi:10.1111/j.1524-4741.2006.00340.x
[9] S. Fulda, S. A. Susin, G. Kroemer and K. M. Debatin, “Molecular Ordering of Apoptosis Induced by Anticancer Drugs in Neuroblastoma Cells,” Cancer Research, Vol. 58, No. 9, 1998, pp. 4453-4460.
[10] T. Mosmann, “Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays,” Journal of Immunological Methods, Vol. 65, No. 1-2, 1983, pp. 55-63. doi:10.1016/0022-1759(83)90303-4
[11] J. Carmichale, W. G. Degraff, A. F. Gazdar, J. D. Minna and J. B. Mitchell, “Evaluation of a Tetrazolium Based Semi-automated Colorimetric Assay: Assessment of Chemo-Sensitivity Testing,” Cancer Research, Vol. 47, No. 4, 1987, p. 936.
[12] B. H. Ali, N. Wabel and G. Blunden, “Phytochemical, Pharmacological and Toxicological Aspects of Hibiscus Sabdariffa L.: A Review,” Phytotherapy Research, Vol. 19, No. 5, 2005, pp. 369-375. doi:10.1002/ptr.1628
[13] A. H. Arellanoa, S. F. Romero, M. A. Soto and J. Tortoriello, “Effectiveness and Tolerability of a Standardized Extract from Hibiscus Sabdariffa in Patients with Mild to Moderate Hypertension: A Controlled and Randomized Clinical Trial,” Phytomedicine, Vol. 11, 2004, pp. 375-382. doi:10.1016/j.phymed.2004.04.001
[14] H. H. Lin, J. H. Chen, W. H. Kuo and C. J. Wang, “Chemopreventive Properties of Hibiscus Sabdariffa L. on Human Gastric Carcinoma Cells through Apoptosis Induction and JNK/p38 MAPK Signaling Activation,” Chemico-Biological Interactions, Vol. 165, No. 1, 2007, pp. 59-75. doi:10.1016/j.cbi.2006.10.011
[15] H. H. Lin, J. H. Chen, W. H. Kuo and C. J. Wang, “Hibiscus Polyphenol-Rich Extract Induces Apoptosis in Human Gastric Carcinoma Cells via p53 Phosphorylation and p38 MAPK/FasL Cascade Pathway,” Molecular Carcinogenesis, Vol. 43, No. 2, 2005, pp. 86-99. doi:10.1002/mc.20103
[16] L. T. Lin, L. T. Liu, L. C. Chiang and C. C. Lin, “In vitro Anti-hepatoma Activity of Fifteen Natural Medicines from Canada,” Phytotherapy Research, Vol. 16, No. 5, 2002, pp. 440-444. doi:10.1002/ptr.937
[17] D. X. Hou, X. Tong, N. Terahara, D. Luo and M. Fujii, “Delphinidin 3-Sambubioside, a Hibiscus Anthocyanin, Induces Apoptosis in Human Leukemia Cells through Reactive Oxygen Species-Mediated Mitochondrial Pathway,” Archives of Biochemistry and Biophysics, Vol. 440, No. 1, 2005, pp. 101-109. doi:10.1016/j.abb.2005.06.002
[18] Y. C. Chang, H. P. Huang, J. D. Hsu, S. F. Yang and C. J. Wang, “Hibiscus Anthocyanins Rich Extract-Induced Apoptotic Cell Death in Human Promyelocytic Leukemia Cells,” Toxicology and Applied Pharmacology, Vol. 205, No. 3, 2005, pp. 201-212. doi:10.1016/j.taap.2004.10.014
[19] T. H. Tseng, T. W. Kao, C. Y. Chu, F. P. Chou, W. L. Lin and C. J. Wang, “Induction of Apoptosis by Hibiscus Protocatechuic Acid in Human Leukemia Cells via Reduction of Retinoblastoma (RB) Phosphorylation and Bcl-2 Expression,” Biochemical Pharmacology, Vol. 60, No. 3, 2000, pp. 307-315. doi:10.1016/S0006-2952(00)00322-1
[20] H. L. Liu, W. B. Jiang and M. X. Xie, “Flavonoids: Recent Advances as Anticancer Drugs,” Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, No. 2, 2010, pp. 152-164. doi:10.2174/157489210790936261
[21] C. Fimognari, M. Lenzi and P. Hrelia, “Chemoprevention of Cancer by Isothiocyanates and Anthocyanins: Mechanisms of Action and Structure-Activity Relationship,” Current Medicinal Chemistry, Vol. 15, No. 5, 2008, pp. 440-447. doi:10.2174/092986708783503168
[22] L. S. Wang and G. D. Stoner, “Anthocyanins and Their Role in Cancer Prevention,” Cancer Letters, Vol. 269, No. 2, 2008, pp. 281-290. doi:10.1016/j.canlet.2008.05.020
[23] H. Fujiki, “Green Tea: Health Benefits as Cancer Preventive for Humans,” Chemical Record, Vol. 5, No. 3, 2005, pp. 119-132. doi:10.1002/tcr.20039
[24] Y. Clement, “Can Green Tea Do That? A Literature Review of the Clinical Evidence,” Preventive Medicine, Vol. 49, No. 2-3, 2009, pp. 83-87. doi:10.1016/j.ypmed.2009.05.005
[25] E. P. Moiseeva and M. M. Manson, “Dietary Chemopreventive Phytochemicals: Too Little or Too Much?” Cancer Prevention Research, Vol. 2, No. 7, 2009, pp. 611-616. doi:10.1158/1940-6207.CAPR-08-0102
[26] L. Orlando, P. Schiavone, P. Fedele, N. Calvani, A. Nacci, P. Rizzo, A. Marino, M. D’Amico, F. Sponziello, E. Mazzoni, M. Cinefra, N. Fazio, E. Maiello, N. Silvestris, G. Colucci and S. Cinieri, “Molecularly Targeted Endocrine Therapies for Breast Cancer,” Cancer Treatment Reviews, Vol. 36, 2010, pp. S67-S71. doi:10.1016/S0305-7372(10)70023-2
[27] C. A. Lamartiniere, “Protection against Breast Cancer with Genistein: A Component of Soy,” The American Journal of Clinical Nutrition, Vol. 71, No. 6, 2000, pp. 1705S-1707S.
[28] M. T. Subbiah and W. Abplanalp, “Ergosterol (Major Sterol of Baker’s and Brewer’s Yeast Extracts) Inhibits the Growth of Human Breast Cancer Cells in vitro and the Potential Role of Its Oxidation Products,” International Journal for Vitamin and Nutrition Research, Vol. 73, No. 1, 2003, pp. 19-23. doi:10.1024/0300-9831.73.1.19
[29] Y. H. Ju, L. M. Clausen, K. F. Allred, A. L. Almada and W. G. Helferich, “Beta-Sitosterol, Beta-Sitosterol Glucoside, and a Mixture of Beta-Sitosterol and Beta-Sitosterol Glucoside Modulate the Growth of Estrogen-Responsive Breast Cancer Cells in vitro and in Ovariectomized Athymic Mice,” Journal of Nutrition, Vol. 134, No. 5, 2004, pp. 1145-1151.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.